期刊文献+

抗精神病药治疗精神分裂症急性期兴奋激越症状早期反应对四周疗效的预测作用 被引量:14

原文传递
导出
摘要 抗精神病药是精神分裂症治疗的主要策略,并且主要治疗作用发生在前4周。近年来,有研究发现药物的早期反应与后期疗效存在关联。精神分裂症急性期常伴有兴奋激越症状,给临床治疗和患者管理带来巨大困难。我们通过评估口服抗精神病药治疗精神分裂症急性期兴奋激越症状的早期反应和急性期疗效,探索早期反应与总体疗效间的关联。
出处 《中华精神科杂志》 CAS CSCD 北大核心 2013年第5期307-308,共2页 Chinese Journal of Psychiatry
  • 相关文献

参考文献8

  • 1Agid O, Kapur S, Arenovich T,et al. Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected. Arch Gen Psychiatry, 2003,60 : 1228-1235.
  • 2Leucht S, Busch R, Hamann J, et al. Early-onset hypothesis of antipsyehotic drug action: a hypothesis tested, confirmed and extended. Biol Psychiatry,2005,57 : 1543-1549.
  • 3Stauffer VL, Case M, Kinon B J, et al. Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis. Psychiatry Res ,2011,187 ( 1-2 ) :42-48.
  • 4梁英,苏允爱,黄继忠,唐茂芹,栗克清,杨甫德,司天梅,于欣.喹硫平和氟哌啶醇治疗精神分裂症急性期兴奋激越的多中心随机对照研究[J].中国心理卫生杂志,2013,27(4):262-267. 被引量:46
  • 5世界卫生组织.ICD-10精神与行为障碍分类,临床描述与诊断要点[M].北京:人民卫生出版社,1993.197-198.
  • 6何燕玲,张明园.阳性和阴性综合征量表(PANSS)及其应用[J].临床精神医学杂志,1997,7(6):353-355. 被引量:475
  • 7Davis JM, Chen N, Glick ID. A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry,2003,60 : 553-564.
  • 8Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsyehoties. J Clin Psychiatry,2003,64:663-667.

二级参考文献11

  • 1蔡焯基.精神分裂症急性兴奋与激越的治疗[J].中华医学信息导报,2004,19(5):21-21. 被引量:2
  • 2王慧芳,沈婷,余一旻,刘登堂,王飚,江开达,郭晓云,诸索宇,凌政.奎硫平与氟哌啶醇治疗精神分裂症兴奋激越症状的对照研究[J].上海精神医学,2005,17(5):271-274. 被引量:4
  • 3世界卫生组织 范肖冬 汪向东 于欣 译.ICD-10精神与行为障碍分类临床描述与诊断要点[M].北京:人民卫生出版社,1993.70-106.
  • 4Addonizio G, Alexopoulos GS. Drug-induced dystonia in young and elderly patients [J]. Am J Psychiatry, 1988, 145 (7):869 - 871.
  • 5Cheer SM, Wagstaff AJ. Quetiapine: a review of its use in the man- agement of schizophrenia [ J]. CNS Drug, 2004, 18 (3) : 173 - 199.
  • 6Schulz SC, Thomson R, Brecher M, et al. The efficacy of quetiap- ine vs haloperidol and placebo: a meta-analytic study of efficacy [ J]. Schizophr Res, 2003, 62 ( 1 - 2) : 1 - 12.
  • 7Chengappa KN, Goldstein JM, Greenwood M, et al. A post hoc a- nalysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia [J]. Clin Ther, 2003, 25(2) : 530 - 541.
  • 8Battaglia J, Moss S, Rush J. Haloperidol, lorazeparn, or both for psychotic agitation? A multicenter, prospective, double-blind, emer- gency department study [J]. Am J Emerg Med, 1997, 15(4) : 335 - 340.
  • 9Haddad PM, Wieck A. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management [ J]. Drugs, 2004, 64 (20) : 2291 - 2314.
  • 10张英辉.喹硫平联合氯硝西泮治疗精神分裂症急性兴奋疗效观察[J].精神医学杂志,2008,21(1):59-60. 被引量:6

共引文献518

同被引文献106

引证文献14

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部